Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.

Martin, Paul; Clarke, Candice

Martin, Paul; Clarke, Candice.

Martin P; Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom. Electronic address: paul.martin9@nhs.net.
Clarke C; Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom.

EBioMedicine ; 71: 103567, 2021 Sep.

Article in English | MEDLINE | ID: covidwho-1375923

Subject(s)

Antibodies, Viral/immunology; COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; Spike Glycoprotein, Coronavirus/immunology; Antibodies, Neutralizing/immunology; COVID-19/immunology; COVID-19/virology; COVID-19 Vaccines/immunology; Humans; RNA, Messenger/immunology; RNA, Messenger/therapeutic use; Renal Dialysis/adverse effects; SARS-CoV-2/immunology; SARS-CoV-2/pathogenicity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / COVID-19 / Antibodies, Viral Topics: Vaccines Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google